Search Results - "Byrne, Jennifer L." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT

Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT

by Gilleece, Maria H., Labopin, Myriam, Savani, Bipin N., Yakoub-Agha, Ibrahim, Socié, Gerard, Gedde-Dahl, Tobias, Blaise, Didier, Byrne, Jennifer L., Craddock, Charles, Cornelissen, Jan J., Arcese, William, Forcade, Edouard, Crawley, Charles, Polge, Emmanuelle, Mohty, Mohamad, Nagler, Arnon
Published in Leukemia (01.01.2020)

Get full text

Journal Article

Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT)

Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT)

by Beksac, Meral, Kröger, Nicolaus, Byrne, Jennifer L., Ganser, Arnold, Yeğin, Zeynep Arzu, Schönland, Stefan
Published in Bone marrow transplantation (Basingstoke) (01.03.2021)

Get full text

Journal Article

Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?

Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?

by Scheid, Christof, Eikema, Diderik-Jan, van Gelder, Michel, Salmenniemi, Urpu, Maertens, Johan, Passweg, Jakob, Blaise, Didier, Byrne, Jennifer L., Kröger, Nicolaus, Sockel, Katja, Chevallier, Patrice, Bourhis, Jean Henri, Cornelissen, Jan J., Sengeloev, Henrik, Finke, Jürgen, Snowden, John A., Gedde-Dahl, Tobias, Cornillon, Jérôme, Schanz, Urs, Patel, Amit, Koster, Linda, de Wreede, Liesbeth C., Hayden, Patrick, Raj, Kavita, Drozd-Sokolowska, Joanna, Gurnari, Carmelo, Onida, Francesco, McLornan, Donal P., Robin, Marie, Yakoub-Agha, Ibrahim
Published in Blood (25.07.2024)

Get full text

Journal Article

Survivorship care for allogeneic transplant patients in the UK NHS: changes centre practice, impact of health service policy and JACIE accreditation over 5 years

Survivorship care for allogeneic transplant patients in the UK NHS: changes centre practice, impact of health service policy and JACIE accreditation over 5 years

by Dignan, Fiona L., Hamblin, Angela, Chong, Amelia, Lee, Julia, Kenyon, Michelle, Miller, Paul, Gilleece, Maria, Hunter, Hannah, Snowden, John A.
Published in Bone marrow transplantation (Basingstoke) (01.03.2021)

Get full text

Journal Article

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients

by Faulkner, Rowena D., Craddock, Charles, Byrne, Jennifer L., Mahendra, Prem, Haynes, Andrew P., Prentice, Hugh G., Potter, Michael, Pagliuca, Antonio, Ho, Aloysius, Devereux, Stephen, McQuaker, Grant, Mufti, Ghulam, Yin, John Liu, Russell, Nigel H.
Published in Blood (15.01.2004)

Get full text

Journal Article

Pepperpot or not?

Pepperpot or not?

by Harvey, Caroline M., Gallagher, Rebecca G., Fairbairn, Karen J., Byrne, Jennifer L.
Published in British journal of haematology (01.08.2013)

Get full text

Journal Article

Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution

Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution

by Klangsinsirikul, Phennapha, Carter, G. Ian, Byrne, Jennifer L., Hale, Geoff, Russell, Nigel H.
Published in Blood (01.04.2002)

Get full text

Journal Article

Unrelated donor peripheral blood stem cell transplants incorporating pre‐transplant in‐vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft‐versus‐host disease

Unrelated donor peripheral blood stem cell transplants incorporating pre‐transplant in‐vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft‐versus‐host disease

by Shaw, Bronwen E., Apperley, Jane F., Russell, Nigel H., Craddock, Charles, Liakopoulou, Effie, Potter, Michael N., Wynn, Robert, Gibson, Brenda, Pearce, Rachel M., Kirkland, Keiren, Lee, Julia, Madrigal, J. Alejandro, Cook, Gordon, Byrne, Jennifer L.
Published in British journal of haematology (01.04.2011)

Get full text

Journal Article

Outcome of BEAM‐autologous and BEAM‐alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma

Outcome of BEAM‐autologous and BEAM‐alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma

by Ingram, Wendy, Devereux, Stephen, Das‐Gupta, Emma P., Russell, Nigel H., Haynes, Andrew P., Byrne, Jennifer L., Shaw, Bronwen E., McMillan, Andrew, Gonzalez, Juan, Ho, Aloysius, Mufti, Ghulam J., Pagliuca, Antonio
Published in British journal of haematology (01.04.2008)

Get full text

Journal Article

$Combination chemotherapy with cyclophosphamide, thalidomide and dexamethasone for patients with refractory, newly diagnosed or relapsed myeloma$

Combination chemotherapy with cyclophosphamide, thalidomide and dexamethasone for patients with refractory, newly diagnosed or relapsed myeloma

by Sidra, G, Williams, CD, Russell, NH, Zaman, S, Myers, B, Byrne, JL
Published in Haematologica (Roma) (01.06.2006)

Get full text

Journal Article

Expert radiological review of skeletal surveys identifies additional abnormalities in 23% of cases: further evidence for the value of myeloma multi‐disciplinary teams in the accurate staging and treatment of myeloma patients

Expert radiological review of skeletal surveys identifies additional abnormalities in 23% of cases: further evidence for the value of myeloma multi‐disciplinary teams in the accurate staging and treatment of myeloma patients

by Singh, Jas, Fairbairn, K. Julia, Williams, Catherine, Das‐Gupta, Emma P., Russell, Nigel H., Byrne, Jennifer L.
Published in British journal of haematology (01.04.2007)

Get full text

Journal Article

Outcomes following 50 mg versus 100 mg alemtuzumab in reduced‐intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia

Outcomes following 50 mg versus 100 mg alemtuzumab in reduced‐intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia

by Tholouli, Eleni, Liakopoulou, Effie, Greenfield, Hayley M., Shaw, Bronwen E., Tauro, Sudhir, Byrne, Jennifer L., Dennis, Mike, Burthem, John, Lucas, Guy S., Craddock, Charles, Russell, Nigel H., Liu Yin, John A.
Published in British journal of haematology (01.07.2008)

Get full text

Journal Article

The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors

The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors

by Shaw, BE, Russell, NH, Devereux, S, Das-Gupta, E, Mackinnon, S, Madrigal, JA, Pagliuca, A, Mufti, GJ, Byrne, JL
Published in Haematologica (Roma) (01.11.2005)

Get full text

Journal Article

CMV infection following nonmyeloablative allogeneic stem cell transplantation using Campath

CMV infection following nonmyeloablative allogeneic stem cell transplantation using Campath

by Bainton, Rowena D., Byrne, Jennifer L., Davy, Barbara J., Russell, Nigel H.
Published in Blood (15.11.2002)

Get full text

Journal Article

Allogeneic hematopoietic cell transplantation

Allogeneic hematopoietic cell transplantation

by Beksac, Meral, Kröger, Nicolaus, Byrne, Jennifer L, Ganser, Arnold, Yegin, Zeynep Arzu, Schönland, Stefan
Published in Bone marrow transplantation (Basingstoke) (01.03.2021)

Get full text

Journal Article

Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?

Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?

by Scheid, Christof, Eikema, Diderik-Jan, van Gelder, Michel, Salmenniemi, Urpu, Maertens, Johan, Passweg, Jakob, Blaise, Didier, Byrne, Jennifer L., Kroeger, Nicolaus, Sockel, Katja, Chevallier, Patrice, Bourhis, Jean Henri, Cornelissen, Jan J., Sengeloev, Henrik, Finke, Jürgen, Snowden, John A., Gedde-Dahl, Tobias, Cornillon, Jérôme, Schanz, Urs, Patel, Amit, Koster, Linda, de Wreede, Liesbeth C., Hayden, Patrick, Raj, Kavita, Drozd-Sokolowska, Joanna, Gurnari, Carmelo, Onida, Francesco, Mclornan, Donal P., Robin, Marie, Yakoub-Agha, Ibrahim
Published in Blood (25.07.2024)

Get full text

Journal Article

The Target UK Study: Real-World Evidence of Molecular Response to Tyrosine Kinase Inhibitors Supports European Leukemianet 2013 Recommendations for the Management of Chronic Myeloid Leukaemia

The Target UK Study: Real-World Evidence of Molecular Response to Tyrosine Kinase Inhibitors Supports European Leukemianet 2013 Recommendations for the Management of Chronic Myeloid Leukaemia

by Milojkovic, Dragana, Clark, Richard E., Byrne, Jennifer L, Huntly, Brian J.P, Raghavan, Manoj, Wandroo, Farooq A, Ali, Sahra, Austen, Belinda, Ryan, Jacqueline, Friedrich, Karsten, Cross, Nicholas C.P., Mead, Adam J
Published in Blood (08.12.2017)

Get full text

Journal Article

Long-Term Outcome of Unrelated Donor Transplantation for AML Using Myeloablative Conditioning Incorporating Pretransplant Alemtuzumab

Long-Term Outcome of Unrelated Donor Transplantation for AML Using Myeloablative Conditioning Incorporating Pretransplant Alemtuzumab

by Das-Gupta, Emma P, Russell, Nigel H, Shaw, Bronwen E, Pearce, Rachel M, Byrne, Jennifer L
Published in Biology of blood and marrow transplantation (01.06.2007)

Get full text

Journal Article

Unrelated donor peripheral blood stem cell transplants incorporating preatransplant inavivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graftaversusahost disease

Unrelated donor peripheral blood stem cell transplants incorporating preatransplant inavivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graftaversusahost disease

by Shaw, Bronwen E, Apperley, Jane F, Russell, Nigel H, Craddock, Charles, Liakopoulou, Effie, Potter, Michael N, Wynn, Robert, Gibson, Brenda, Pearce, Rachel M, Kirkland, Keiren, Lee, Julia, Madrigal, JAlejandro, Cook, Gordon, Byrne, Jennifer L
Published in British journal of haematology (01.04.2011)

Get full text

Journal Article

Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic GVHD

Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic GVHD

by Shaw, Bronwen E, Apperley, Jane, Russell, Nigel H, Craddock, Charles, Liakopoulou, Effie, Potter, M, Wynn, Robert F, Gibson, Brenda, Pearce, Rachel M, Kirkland, Keiren, Lee, Julia, Madrigal, Alejandro, Cook, Gordon, Byrne, Jennifer L
Published in British journal of haematology (08.03.2011)

Get full text

Journal Article